Senicapoc treatment in COVID-19 patients with severe respiratory insufficiency-A randomized, open-label, phase II trial.
Asger GranfeldtLars Wiuff AndersenMikael F VallentinOle HilbergJørgen B HasselstrømLambert K SørensenSusie MogensenSteffen ChristensenAnders M GrejsBodil Steen RasmussenKlaus T KristiansenThomas StrømIsik S JohansenOlav Lilleholt SchjørringUlf SimonsenPublished in: Acta anaesthesiologica Scandinavica (2022)
ratio at 72 h with no differences for other outcomes.